Debates on tobacco and nicotine policy within the European Union have often been characterised by strong views and high levels of engagement. This reflects the importance of the issue. Tobacco use remains a leading cause of preventable disease, and decisions taken by policymakers have long-term implications for public health across Member States. However, the intensity…
Across the European Union, tobacco control policy has long focused on reducing smoking prevalence through a combination of regulatory restrictions, public health campaigns, and excise taxation. These approaches have contributed to meaningful progress over time. However, smoking remains a leading cause of preventable disease, and reducing its impact continues to be a central objective of…
European tobacco and nicotine policy is shaped by several regulatory instruments. Among the most important are the Tobacco Products Directive (TPD), which establishes product standards and regulatory requirements, and the Tobacco Excise Directive (TED), which governs how tobacco products are taxed across the European Union. Although these two frameworks address different aspects of regulation, their…
Public health policy often develops through long institutional processes. Regulations are debated, negotiated, and revised through multiple stages of consultation and political review. This is particularly true in the European Union, where legislative frameworks such as the Tobacco Products Directive (TPD) and the Tobacco Excise Directive (TED) shape tobacco and nicotine policy across all Member…
The revision of the European Union’s Tobacco Excise Directive (TED) presents an important moment for policymakers to reconsider how taxation influences tobacco and nicotine use across Member States. While excise policy is often described as a technical fiscal instrument, its impact extends far beyond government revenue. Tax policy directly shapes consumer behaviour, market dynamics, and…
The European Union’s Tobacco Products Directive (TPD) is entering another period of review. These revisions are not frequent. When they occur, they shape the regulatory environment for many years to come, influencing product standards, market access, and public health policy across all Member States. For those who have worked on EU policy files, the significance…
Debates around nicotine policy often focus narrowly on dependence and youth protection. Far less frequently examined, but increasingly discussed in scientific and policy literature, is nicotine’s relationship with cognition and mental health. Emerging research suggests that nicotine may have measurable short-term effects on attention, working memory, and executive function. At the same time, long-standing concerns…
Excise taxation is one of the most powerful tools in tobacco control. Price signals influence initiation, continuation, cessation, and product switching. As nicotine markets diversify beyond combustible cigarettes, the question facing policymakers is no longer simply whether to tax nicotine products, but how to structure taxation in a way that aligns with relative risk and…
Article 5.3 of the WHO Framework Convention on Tobacco Control (FCTC) has become one of the most frequently cited provisions in contemporary nicotine policy debates. The clause is concise: “In setting and implementing their public health policies with respect to tobacco control, Parties shall act to protect these policies from commercial and other vested interests…
From April 2026, Austria will implement its first fully defined national regulatory framework for nicotine pouches. The reform moves the category from a fragmented legal grey zone into a structured regime anchored in tobacco legislation, combining legal availability with strict controls on youth access, sales channels, product standards, and taxation. The shift is not a…